Why we need basic science to better understand the neurobiology of psychedelics
Despite the many psychedelics clinical trials underway, there is still much we don’t know about how these drugs work. Preclinical studies represent our best viable avenue to answer these lingering questions.
Reproducibility is a team sport: Lessons from a large-scale collaboration
Building reproducible systems across labs is possible, even in large-scale neuroscience projects. You just need rigor, collaboration and the willingness to look your own practices dead in the eye.
Local circuit loops within body control fly behavior, new 'embodied' connectome reveals
The mapping, which traces how the central nervous system interacts with the rest of the body, challenges the idea that behavior control is centralized.
Autism experts question HHS statements on Tylenol, leucovorin
Concerns include the administration’s reliance on weak, correlational evidence rather than established research.
Beyond Newtonian causation in neuroscience: Embracing complex causality
The traditional mechanistic framework must give way to a richer understanding of how brains actually generate behavior over time.